Nuwellis shareholders block warrant share issuance but clear path for reverse split

summarizeSummary

Nuwellis shareholders rejected a proposal to authorize shares for warrant exercises from the June 2026 financing, while approving a reverse stock split to address Nasdaq listing requirements. The failed warrant vote introduces new financing risk for the cash-strapped company.

check_boxKey Events · Corporate Governance and Compliance · NUWE

• Warrant Share Issuance Rejected

  Proposal 1, which sought authorization for shares underlying warrant exercises from the June 2026 financing, failed with 477,084 votes in favor and 216,196 against. Although the tally represents a majority of votes cast, the filing indicates the measure did not pass—likely due to a higher threshold or the impact of broker non-votes. This outcome blocks a key component of the recent $6.0 million capital raise.

• Reverse Split Approved

  Proposal 2 passed with 1,172,689 votes for and 310,588 against, granting the board authority to implement a reverse stock split at a ratio between 1-for-5 and 1-for-70 within 12 months. The move is designed to help the company regain Nasdaq compliance.

• Financing Uncertainty

  The failed warrant vote clouds the terms of the June 2026 financing. Warrant holders may hold repricing or anti-dilution rights, and the company could be forced to seek alternative funding or renegotiate—adding pressure to an already strained cash position.

• Nasdaq Listing at Risk

  The stock trades near its 52-week low of $1.95, well below the $1.00 minimum bid requirement on a post-reverse split adjusted basis. While the approved reverse split offers a path to compliance, the wide ratio range and discretionary timing leave execution uncertain.

auto_awesomeAnalysis · NUWE · Industrial Applications And Services

In a special meeting, Nuwellis shareholders unexpectedly voted down a proposal to authorize shares for warrant exercises tied to the June 2026 financing, effectively blocking a critical piece of that deal. At the same time, they approved a broad reverse split authorization—ranging from 1-for-5 to 1-for-70—to help the company regain Nasdaq compliance. The failed warrant vote injects immediate uncertainty: management may need to renegotiate with warrant holders or pursue alternative financing, all while the going-concern warning and cash runway pressures persist. The approved reverse split gives the board a tool to lift the stock price above $1, but the wide ratio range and discretionary 12-month execution window leave the outcome far from certain.